Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
XENE
|
Ian Mortimer
PRESIDENT & CEO |
SELL
Open market or private sale
|
Direct | 22,468 Reduced 41.79% |
$903,213
$40.2 p/Share
|
Jan 24
2025 |
|
TKO
|
Ariel Emanuel
Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 105,038 Added 0.0% |
$16,098,123
$153.26 p/Share
|
Jan 24
2025 |
|
TKO
|
Patrick Whitesell |
BUY
Open market or private purchase
|
Indirect | 105,038 Added 0.0% |
$16,098,123
$153.26 p/Share
|
Jan 24
2025 |
|
META
|
Mark Zuckerberg
COB and CEO |
SELL
Open market or private sale
|
Indirect | 35,921 Reduced 0.0% |
$23,132,764
$643.99 p/Share
|
Jan 24
2025 |
|
XFOR
|
Christophe Arbet Engels
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 11,624 Reduced 45.0% |
$5,230
$0.45 p/Share
|
Jan 24
2025 |
|
XFOR
|
Mary Di Biase
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 22,258 Reduced 4.34% |
$10,016
$0.45 p/Share
|
Jan 24
2025 |
|
XFOR
|
Mark Baldry
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 29,159 Reduced 23.65% |
$13,121
$0.45 p/Share
|
Jan 24
2025 |
|
XFOR
|
Adam S. Mostafa
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 74,773 Reduced 100.0% |
$33,647
$0.45 p/Share
|
Jan 24
2025 |
|
XFOR
|
Paula Ragan
President and CEO |
SELL
Open market or private sale
|
Direct | 76,473 Reduced 6.57% |
$34,412
$0.45 p/Share
|
Jan 24
2025 |
|
SMC
|
J Heath Deneke
Chairman, President and CEO |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 0.38% |
$42,360
$42.36 p/Share
|
Jan 24
2025 |
|
RDW
|
Genesis Park Ii LP |
SELL
Open market or private sale
|
Direct | 53,448 Reduced 1.33% |
$1,176,924
$22.02 p/Share
|
Jan 24
2025 |
|
TDY
|
Stephen Finis Blackwood
Senior VP and CFO |
SELL
Open market or private sale
|
Direct | 5,046 Reduced 30.04% |
$2,592,634
$513.8 p/Share
|
Jan 24
2025 |
|
SLG
|
Craig M Hatkoff |
SELL
Open market or private sale
|
Direct | 3,455 Reduced 62.74% |
$229,066
$66.3 p/Share
|
Jan 24
2025 |
|
MDT
|
Brett A. Wall
EVP & Pres Neuroscience |
SELL
Open market or private sale
|
Direct | 12,437 Reduced 23.28% |
$1,119,330
$90.0 p/Share
|
Jan 24
2025 |
|
RLI
|
Jennifer L Klobnak
CHIEF OPERATING OFFICER |
BUY
Open market or private purchase
|
Direct | 2,000 Added 2.05% |
$144,200
$72.1 p/Share
|
Jan 24
2025 |
|
RLI
|
Craig W Kliethermes
CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct | 5,000 Added 3.47% |
$356,750
$71.35 p/Share
|
Jan 24
2025 |
|
RLI
|
Jeffrey D Fick
CHIEF LEGAL OFFICER & CORP SEC |
BUY
Open market or private purchase
|
Direct | 2,000 Added 1.39% |
$144,260
$72.13 p/Share
|
Jan 24
2025 |
|
RLI
|
Michael E Angelina |
BUY
Open market or private purchase
|
Direct | 2,200 Added 8.56% |
$159,764
$72.62 p/Share
|
Jan 24
2025 |
|
MDGL
|
Carole Huntsman
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 347 Reduced 3.22% |
$116,328
$335.24 p/Share
|
Jan 24
2025 |
|
SGA
|
Edward K. Christian Trust |
SELL
Open market or private sale
|
Direct | 3,205 Reduced 0.33% |
$40,126
$12.52 p/Share
|
Jan 24
2025 |
|
OKTA
|
Jacques Frederic Kerrest
Director |
SELL
Open market or private sale
|
Direct | 65,000 Reduced 100.0% |
$5,752,500
$88.5 p/Share
|
Jan 24
2025 |
|
OKTA
|
Jacques Frederic Kerrest
Director |
SELL
Open market or private sale
|
Indirect | 9,999 Reduced 0.0% |
$884,911
$88.5 p/Share
|
Jan 24
2025 |
|
MDGL
|
William John Sibold
President and CEO |
SELL
Open market or private sale
|
Direct | 1,584 Reduced 2.83% |
$531,020
$335.24 p/Share
|
Jan 24
2025 |
|
MDGL
|
Rebecca Taub
Pres., R&D, and CMO |
SELL
Open market or private sale
|
Direct | 648 Reduced 0.14% |
$217,235
$335.24 p/Share
|
Jan 24
2025 |
|
MDGL
|
Robert E. Waltermire
Senior VP, Chief Pharma Dev. |
SELL
Open market or private sale
|
Direct | 103 Reduced 2.04% |
$34,529
$335.24 p/Share
|
Jan 24
2025 |
|
SYM
|
Michael David Dunn
Officer |
SELL
Open market or private sale
|
Indirect | 3,635 Reduced 0.0% |
$120,972
$33.28 p/Share
|
Jan 24
2025 |
|
BANX
|
John Scott Emrich
Director |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 28.66% |
$53,200
$21.28 p/Share
|
Jan 24
2025 |
|
ALLY
|
Russell E. Hutchinson
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 19,100 Added 8.61% |
$753,495
$39.45 p/Share
|
Jan 24
2025 |
|
MIRM
|
Peter Radovich
PRESIDENT AND COO |
SELL
Open market or private sale
|
Direct | 3,177 Reduced 9.7% |
$152,241
$47.92 p/Share
|
Jan 24
2025 |
|
IBEX
|
Robert Thomas Dechant
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 200 Reduced 0.09% |
$4,500
$22.5 p/Share
|
Jan 24
2025 |
|
IBEX
|
Mohammedulla Khaishgi
Director |
SELL
Open market or private sale
|
Direct | 400 Reduced 0.18% |
$9,000
$22.5 p/Share
|
Jan 24
2025 |
|
IBEX
|
Mohammedulla Khaishgi
Director |
SELL
Open market or private sale
|
Indirect | 201 Reduced 0.0% |
$4,522
$22.5 p/Share
|
Jan 24
2025 |
|
MIRM
|
Christopher Peetz
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 6,837 Reduced 5.19% |
$327,629
$47.92 p/Share
|
Jan 24
2025 |
|
MIRM
|
Jolanda Howe
SVP, GLOBAL CONTROLLER |
SELL
Open market or private sale
|
Direct | 902 Reduced 20.38% |
$43,223
$47.92 p/Share
|
Jan 24
2025 |
|
JBL
|
John C Plant
Director |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 89.45% |
$8,640,000
$172.8 p/Share
|
Jan 24
2025 |
|
PHR
|
Yvonne Hui
Principal Accounting Officer |
SELL
Open market or private sale
|
Direct | 127 Reduced 0.49% |
$3,556
$28.0 p/Share
|
Jan 24
2025 |
|
ACN
|
Joel Unruch
General Counsel/Corp Secretary |
SELL
Open market or private sale
|
Direct | 4,750 Reduced 18.79% |
$1,720,925
$362.3 p/Share
|
Jan 24
2025 |
|
SNCY
|
John Gyurci
Chief Acct. Off. & VP, Finance |
SELL
Open market or private sale
|
Direct | 1,593 Reduced 12.06% |
$27,081
$17.0 p/Share
|
Jan 24
2025 |
|
SNCY
|
David M Davis
President & CFO |
SELL
Open market or private sale
|
Direct | 35,536 Reduced 52.42% |
$601,269
$16.92 p/Share
|
Jan 24
2025 |
|
TEAM
|
Scott Farquhar |
SELL
Open market or private sale
|
Indirect | 7,948 Reduced 0.0% |
$2,127,838
$267.72 p/Share
|
Jan 24
2025 |
|
TEAM
|
Michael Cannon Brookes
CEO, Co-Founder |
SELL
Open market or private sale
|
Indirect | 7,948 Reduced 0.0% |
$2,127,838
$267.72 p/Share
|
Jan 24
2025 |
|
DASH
|
Ravi Inukonda
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 1,425 Reduced 0.39% |
$261,059
$183.2 p/Share
|
Jan 24
2025 |
|
CBIO
|
Songjiang Ma
President |
SELL
Open market or private sale
|
Indirect | 2,000 Reduced 0.0% |
$21,780
$10.89 p/Share
|
Jan 24
2025 |
|
FNA
|
Mvm Partners, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 25,026 Reduced 0.0% |
$290,301
$11.6 p/Share
|
Jan 24
2025 |
|
CLXT
|
Gerhard Prante
Director |
SELL
Open market or private sale
|
Direct | 1,150 Reduced 3.37% |
$2,990
$2.6 p/Share
|
Jan 24
2025 |
|
MDBH
|
Anthony Digiandomenico
Co-Founder |
BUY
Open market or private purchase
|
Direct | 164 Added 0.19% |
$1,018
$6.21 p/Share
|
Jan 24
2025 |
|
NBBK
|
Hope Pascucci
Director |
BUY
Open market or private purchase
|
Direct | 40,000 Added 49.95% |
$741,200
$18.53 p/Share
|
Jan 24
2025 |
|
TDY
|
Cynthia Y Belak
Vice President and Controller |
SELL
Open market or private sale
|
Direct | 5,745 Reduced 53.66% |
$2,922,079
$508.63 p/Share
|
Jan 24
2025 |
|
TDY
|
George C Bobb Iii
President and COO |
SELL
Open market or private sale
|
Direct | 6,308 Reduced 37.57% |
$3,203,643
$507.87 p/Share
|
Jan 24
2025 |
|
NXJ
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 16,681 Reduced 0.0% |
$200,338
$12.01 p/Share
|
Jan 24
2025 |